Severity Classification of COVID-19 Patients Data using Quantum Machine Learning Approaches
Abstract
Artificial intelligence (AI) is assisting in several aspects of the COVID-19 pandemic, including medical diagnosis and therapy, drug development, molecular research and epidemiology. The involvement of AI in healthcare can help doctors to detect symptoms more quickly. In such era, we use the Quantum Machine Learning (QML) approaches to address clinical applications of machine learning (ML) technology, such as electronic healthcare data and clinical features. This paper presents the two QML algorithms, i.e, Enhanced Quantum Support Vector Machine (E-QSVM) and Quantum Random Forest (QRF) applied to COVID-19 and influenza datasets, which were collected from different private hospitals. The experimental results show that the proposed models outperform in terms of accuracy by achieving the highest accuracy of 78% for the EQSVM model and 75% for the QRF model respectively. The competency of the models is obtained by comparing them with classical models and recently published quantum models.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- Quantum Computing for Healthcare: A Review
- Automated in Silico Design of Homogeneous Catalysts
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.